Cardiovascular Research 2005 67(4):689-698; doi:10.1016/j.cardiores.2005.04.030
Copyright © 2005, European Society of Cardiology
Blockade of NF-
B ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II
Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
* Corresponding author. Tel.: +81 92 642 5360; fax: +81 92 642 5374. Email address: kubotat{at}cardiol.med.kyushu-u.ac.jp
Objective: Nuclear factor (NF)-
B is a key transcription factor that regulates inflammatory processes. In the present study, we assessed the hypothesis that blockade of NF-B may ameliorate ventricular hypertrophy in response to chronic infusion of angiotensin II.
Methods: Mice with targeted disruption of the p50 subunit of NF-B (KO) were used to block the activation of NF-B. Male KO and age-matched wild-type (WT) mice were chronically infused with angiotensin II at the rate of 0.2 (low dose) or 2 µg/kg/min (high dose) for 4 weeks.
Results: High- but not low-dose angiotensin II significantly increased systemic blood pressure and left ventricular weight in WT mice. In contrast, although the pressor response was slightly but significantly augmented, the hypertrophic effect of angiotensin II was significantly attenuated in KO mice. The attenuated hypertrophic responsiveness was confirmed histologically (cross-sectional area) and transcriptionally (atrial natriuretic peptide). Echocardiography revealed no evidence of cardiac dysfunction in angiotensin II-treated KO mice. Although phosphorylation of MAPKs, including ERK, JNK, or p38-MAPK, was not affected after 4 weeks of angiotensin II treatment in WT mice, phosphorylation of JNK was specifically abrogated in KO mice. Angiotensin II increased myocardial expression of proinflammatory cytokines and chemokines in WT mice, while expression of TNF-
and RANTES was paradoxically augmented in KO mice.
Conclusion: Blockade of NF-B activation attenuated myocardial hypertrophy without deteriorating cardiac function. NF-B may play an important role in cardiac hypertrophy and remodeling besides promoting inflammation.
KEYWORDS Angiotensin; Cytokines; Hypertrophy; MAP kinase; Nuclear factor-B; Cardiac remodeling
Time for primary review 24 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Frantz and J. Bauersachs Regarding the Article by Timmers et al Circ. Res., June 5, 2009; 104(11): e60 - e60. [Full Text] [PDF]
|
|
|
|
|
|
L. Timmers and D. P.V. de Kleijn Response to the Letter by Frantz and Bauersachs Circ. Res., June 5, 2009; 104(11): e61 - e61. [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Brunt, M. R. Tsuji, J. H. Lai, R. T. Kinobe, W. Durante, W. C. Claycomb, C. A. Ward, and L. G. Melo Heme Oxygenase-1 Inhibits Pro-Oxidant Induced Hypertrophy in HL-1 Cardiomyocytes Experimental Biology and Medicine, May 1, 2009; 234(5): 582 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. H. Smeets, B. E. J. Teunissen, A. Planavila, H. de Vogel-van den Bosch, P. H. M. Willemsen, G. J. van der Vusse, and M. van Bilsen Inflammatory Pathways Are Activated during Cardiomyocyte Hypertrophy and Attenuated by Peroxisome Proliferator-activated Receptors PPAR{alpha} and PPAR{delta} J. Biol. Chem., October 24, 2008; 283(43): 29109 - 29118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mariappan, R. N. Soorappan, M. Haque, S. Sriramula, and J. Francis TNF-{alpha}-induced mitochondrial oxidative stress and cardiac dysfunction: restoration by superoxide dismutase mimetic Tempol Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2726 - H2737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Frantz, J. Tillmanns, P. J. Kuhlencordt, I. Schmidt, A. Adamek, C. Dienesch, T. Thum, S. Gerondakis, G. Ertl, and J. Bauersachs Tissue-Specific Effects of the Nuclear Factor {kappa}B Subunit p50 on Myocardial Ischemia-Reperfusion Injury Am. J. Pathol., August 1, 2007; 171(2): 507 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-Y. Ho, W. Yan, and C. A. Bagnell Relaxin-induced matrix metalloproteinase-9 expression is associated with activation of the NF-{kappa}B pathway in human THP-1 cells J. Leukoc. Biol., May 1, 2007; 81(5): 1303 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Razeghi, M.-E. Wang, K. A. Youker, L. Golfman, S. Stepkowski, and H. Taegtmeyer Lack of NF-{kappa}B1 (p105/p50) attenuates unloading-induced downregulation of PPAR{alpha} and PPAR{alpha}-regulated gene expression in rodent heart Cardiovasc Res, April 1, 2007; 74(1): 133 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Xu, N. Li, Y. He, V. Timofeyev, L. Lu, H.-J. Tsai, I.-H. Kim, D. Tuteja, R. K. P. Mateo, A. Singapuri, et al. Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors PNAS, December 5, 2006; 103(49): 18733 - 18738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Chung and G. Y.H. Lip Platelets and heart failure Eur. Heart J., November 2, 2006; 27(22): 2623 - 2631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Jhaveri, V. Ramkumar, R. A. Trammell, and L. A. Toth Spontaneous, homeostatic, and inflammation-induced sleep in NF-{kappa}B p50 knockout mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1516 - R1526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Frantz, K. Hu, B. Bayer, S. Gerondakis, J. Strotmann, A. Adamek, G. Ertl, and J. Bauersachs Absence of NF-{kappa}B subunit p50 improves heart failure after myocardial infarction FASEB J, September 1, 2006; 20(11): 1918 - 1920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kawano, T. Kubota, Y. Monden, T. Tsutsumi, T. Inoue, N. Kawamura, H. Tsutsui, and K. Sunagawa Blockade of NF-{kappa}B improves cardiac function and survival after myocardial infarction Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1337 - H1344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pelletier and D. Girard Differential Effects of IL-15 and IL-21 in Myeloid (CD11b+) and Lymphoid (CD11b-) Bone Marrow Cells J. Immunol., July 1, 2006; 177(1): 100 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Piper and E. A. Martinson Cardiovascular Research speeds up-Even more Cardiovasc Res, March 1, 2006; 69(4): 773 - 776. [Full Text] [PDF]
|
|